Wellington Management Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-7,746,382
| Closed | -$64.8M | – | 2028 |
|
|
2019
Q4 | $64.8M | Sell |
7,746,382
-3,136,700
| -29% | -$26.3M | 0.01% | 692 |
|
|
2019
Q3 | $98.5M | Sell |
10,883,082
-156,903
| -1% | -$1.42M | 0.02% | 551 |
|
|
2019
Q2 | $119M | Buy |
11,039,985
+6,726,532
| +156% | +$72.4M | 0.03% | 520 |
|
|
2019
Q1 | $41.2M | Buy |
4,313,453
+2,264,728
| +111% | +$21.6M | 0.01% | 808 |
|
|
2018
Q4 | $23.5M | Buy |
2,048,725
+879,507
| +75% | +$10.1M | 0.01% | 942 |
|
|
2018
Q3 | $19.8M | Buy |
1,169,218
+1,016,644
| +666% | +$17.2M | ﹤0.01% | 1087 |
|
|
2018
Q2 | $2.17M | Sell |
152,574
-23,443
| -13% | -$333K | ﹤0.01% | 1706 |
|
|
2018
Q1 | $3.34M | Buy |
176,017
+43,515
| +33% | +$827K | ﹤0.01% | 1606 |
|
|
2017
Q4 | $2.17M | Buy |
+132,502
| New | +$2.17M | ﹤0.01% | 1708 |
|
|
2016
Q3 | – | Sell |
-85,500
| Closed | -$495K | – | 2209 |
|
|
2016
Q2 | $495K | Sell |
85,500
-45,200
| -35% | -$262K | ﹤0.01% | 1903 |
|
|
2016
Q1 | $791K | Buy |
+130,700
| New | +$791K | ﹤0.01% | 1854 |
|
|
2015
Q4 | – | Sell |
-413,720
| Closed | -$2.33M | – | 2215 |
|
|
2015
Q3 | $2.33M | Buy |
413,720
+2,140
| +0.5% | +$12.1K | ﹤0.01% | 1583 |
|
|
2015
Q2 | $4.57M | Buy |
411,580
+6,540
| +2% | +$72.5K | ﹤0.01% | 1425 |
|
|
2015
Q1 | $6.35M | Buy |
405,040
+9,660
| +2% | +$151K | ﹤0.01% | 1371 |
|
|
2014
Q4 | $6.01M | Sell |
395,380
-53,100
| -12% | -$808K | ﹤0.01% | 1393 |
|
|
2014
Q3 | $4.84M | Buy |
448,480
+43,360
| +11% | +$468K | ﹤0.01% | 1448 |
|
|
2014
Q2 | $6.19M | Buy |
+405,120
| New | +$6.19M | ﹤0.01% | 1404 |
|
|
2013
Q3 | – | Sell |
-67,800
| Closed | -$530K | – | 2229 |
|
|
2013
Q2 | $530K | Buy |
+67,800
| New | +$530K | ﹤0.01% | 1912 |
|